BREAST CANCER: Capecitabine cuts risk of breast cancer recurrence Depression front-runnerNew-generation antidepressant sertraline has best balance between benefits, acceptability and cost Genetic clues may aid preterm prevention EDITORIAL: Ontario's LHINs still in the pressure cooker Canadians' annual Rx spend = $578 Study indicates three out of four Canadians filling at least one prescription annually BREAST CANCER: Toremifene matches tamoxifen in early stage breast cancer outcomes BREAST CANCER: Reduced breast density indicates tamoxifen effect CA and Healthscreen form partnership Chronic disease programs for doctors Winnipeg Shriners satellite clinic opens To assess and diagnose orthopaedic cases EHR faces privacy challenges Alberta doctors balk at sharing data First Previous 2335 2336 2337 2338 2339 Next Last